/ database / GHRH Analog

CJC-1295 with DAC

Also: CJC-1295 DAC · Drug Affinity Complex

Long-acting GHRH analog dosed weekly, distinct from the no-DAC version.

Evidence

emerging

Legal status

research only

Half-life

Long (days+)

Routes

subq

What it is

Long-acting GHRH analog dosed weekly, distinct from the no-DAC version.

Mechanism

Long-acting GHRH analog dosed weekly, distinct from the no-DAC version.

Outcomes it's matched to

Lean muscle
Lean Muscle & Strength
Reported lean muscle benefit in current literature.
STRENGTH
70%
Recovery
Recovery & Tissue Repair
Reported recovery benefit in current literature.
STRENGTH
70%
Sleep
Sleep & Deep Rest
Reported sleep benefit in current literature.
STRENGTH
70%
Fat loss
Fat Loss & Body Composition
Reported fat loss benefit in current literature.
STRENGTH
70%

Safety

Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.

Legal context

Research chemical

Have questions about this peptide?